Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other 1

Conditions

Breast Neoplasms 60Lung Neoplasms 31Colorectal Neoplasms 26Prostatic Neoplasms 24Colonic Neoplasms 18Rectal Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Uterine Cervical Neoplasms 15Neoplasms 14Lymphoma 11Depression 10Urinary Bladder Neoplasms 9Unspecified Adult Solid Tumor, Protocol Specific 9Endometrial Neoplasms 9Ovarian Neoplasms 8Leukemia 8Hematologic Neoplasms 8Fatigue 8Breast Carcinoma In Situ 8Anxiety Disorders 8Pancreatic Neoplasms 7Pain 7Melanoma 7Leukemia, Myeloid, Acute 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Papillomavirus Infections 6Obesity 6Multiple Myeloma 6Carcinoma, Ovarian Epithelial 6Small Cell Lung Carcinoma 5

Interventions

Standard of Care 1Spinal Cord Stimulation 1Specimen Handling 1Practice Guidelines as Topic 1Methods 1Massage 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chemotherapy-Induced Peripheral Neuropathy × Early Intervention, Educational × Clear all
NCT07365007 2026-03-03

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

University of Michigan Rogel Cancer Center

Phase NA Recruiting
50 enrolled
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡